JPRN-jRCTs051190010已完成4 期
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients with Cancer Study - ONCO DVT Study
Yamashita Yugo0 个研究点目标入组 605 人开始时间: 2019年4月24日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 605
研究概览
简要总结
In cancer patients with deep-vein thrombosis confined to the leg, 12 months of edoxaban treatment was better than 3 months of edoxaban treatment in recurrence of symptomatic venous thromboembolism and venous thromboembolism-related deaths. It was shown to be excellent as per the research hypothesis.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with newly found isolated distal deep vein thrombosis complicated with active cancer who are scheduled to be treated by anticoagulation therapy.
排除标准
- •1. Patients with anticoag ulation therapy for the Index event before 10 days of allocation.
- •2. Patient under anticoag ulation therapy for the purpose of other than the Index event.
- •3. Patients with thrombolysis therapy or IVC filter at the Index event.
- •4. Patients with creatinine clearance less than 30 ml/min.
- •5. Patients who are expected to have a life prognosis of 3 months or less.
- •6. Patients with pulmonary embolism.
- •7. Patients who are not appropriate for the participation of the study.
研究者
相似试验
Unknown
4 期
Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein ThrombosisDeep Vein ThrombosisCancerNCT00450645Azienda Ospedaliera Universitaria Policlinico300
已完成
不适用
Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)Venous ThromboembolismNCT02952599Daiichi Sankyo352
已完成
不适用
Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in EuropeVenous ThromboembolismNCT02943993Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2,809
已完成
4 期
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer StudyNeoplasmsAnticoagulantVenous ThrombosisNCT03895502Takeshi Morimoto605
已完成
4 期
Absence of Residual Vein Thrombosis Permits to Withdrawn Oral AnticoagulantsDeep Vein ThrombosisNCT00623987Azienda Ospedaliera Universitaria Policlinico500